The competitive landscape of the China diabetic retinopathy market is undergoing significant transformation, driven by an urgent need for advanced treatments and enhanced diagnostic solutions. The market share is increasingly concentrated among a handful of industry leaders, indicating a shift towards a more collaborative approach in tackling diabetes-related eye complications. Current insights...